As-Needed Budesonide/Formoterol Similar to Maintenance Budesonide Plus SABA in Patients with Mild Asthma

被引:0
|
作者
Ebell, Mark H. [1 ]
机构
[1] Univ Georgia, Athens, GA 30602 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:646 / 647
页数:2
相关论文
共 50 条
  • [21] Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Barnes, Peter J.
    Zhong, Nanshan
    Keen, Christina
    Jorup, Carin
    Lamarca, Rosa
    Ivanov, Stefan
    Reddel, Helen K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20): : 1865 - 1876
  • [22] Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma
    Beasley, Richard
    Holliday, Mark
    Reddel, Helen K.
    Braithwaite, Irene
    Ebmeier, Stefan
    Hancox, Robert J.
    Harrison, Tim
    Houghton, Claire
    Oldfield, Karen
    Papi, Alberto
    Pavord, Ian D.
    Williams, Mathew
    Weatherall, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (21): : 2020 - 2030
  • [23] The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK
    FitzGerald, J. Mark
    Arnetorp, Sofie
    Smare, Caitlin
    Gibson, Danny
    Coulton, Karen
    Hounsell, Kirsty
    Golam, Sarowar
    Sadatsafavi, Mohsen
    RESPIRATORY MEDICINE, 2020, 171
  • [24] Efficacy of budesonide/formoterol maintenance and reliever therapy in mild asthma
    Jenkins, Christine
    Eriksson, Goeran
    Bateman, Eric D.
    Reddel, Helen K.
    Sears, Malcolm R.
    Fageras, Malin
    Lindberg, Magnus B.
    O'Byrne, Paul M.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [25] The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
    Mohsen Sadatsafavi
    J. Mark FitzGerald
    Paul M. O’Byrne
    Mena Soliman
    Niroshan Sriskandarajah
    Colin Vicente
    Sarowar Muhammad Golam
    Allergy, Asthma & Clinical Immunology, 17
  • [26] The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
    Sadatsafavi, Mohsen
    FitzGerald, J. Mark
    O'Byrne, Paul M.
    Soliman, Mena
    Sriskandarajah, Niroshan
    Vicente, Colin
    Golam, Sarowar Muhammad
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2021, 17 (01):
  • [27] Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
    J. Mark FitzGerald
    Paul M. O’Byrne
    Eric D. Bateman
    Peter J. Barnes
    Jinping Zheng
    Stefan Ivanov
    Rosa Lamarca
    Ulrika Larsdotter
    Ulrika Emerath
    Gerreke Jansen
    Margareta Puu
    Vijay K. T. Alagappan
    Filip Surmont
    Helen K. Reddel
    Drug Safety, 2021, 44 : 467 - 478
  • [28] Influence of Prior Treatment Upon the Efficacy of As-Needed Budesonide/Formoterol in Mild Asthma in the SYGMA 1 and 2 Studies
    Bateman, E.
    O'Byrne, P. M.
    FitzGerald, J. M.
    Barnes, P. J.
    Zhong, N.
    Alagappan, V.
    Whelan, G.
    Lamarca, R.
    Puu, M.
    Reddel, H. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
    FitzGerald, J. Mark
    O'Byrne, Paul M.
    Bateman, Eric D.
    Barnes, Peter J.
    Zheng, Jinping
    Ivanov, Stefan
    Lamarca, Rosa
    Larsdotter, Ulrika
    Emerath, Ulrika
    Jansen, Gerreke
    Puu, Margareta
    Alagappan, Vijay K. T.
    Surmont, Filip
    Reddel, Helen K.
    DRUG SAFETY, 2021, 44 (04) : 467 - 478
  • [30] Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma
    Antonio Buendia, Jefferson
    Guerrero Patino, Diana
    Lucio Talamoni, Hernan
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3699 - 3705